Mingzhu P. Huang
130 Dong' An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
A Phase II Clinical Trial of Chemotherapy Rechallenge with or without Targeted Therapy in Refractory Metastatic Colorectal Cancer.
Journal: Oncology research
Published: April 21, 2026
Genomic landscape and fine-scale population structure of Helicobacter pylori across China.
Journal: Biomarker research
Published: January 14, 2026
Paclitaxel oral solution versus paclitaxel injection as second-line therapy for advanced gastric cancer: a multicenter, open-label, randomized phase III trial.
Journal: ESMO open
Published: December 29, 2025
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Journal: Nature medicine
Published: March 27, 2025
Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling.
Journal: Cancer biology & medicine
Published: February 22, 2025
Transcriptome Landscape of Cancer-Associated Fibroblasts in Human PDAC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 18, 2024
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Journal: Nature medicine
Published: September 29, 2024
Hepatic resection improves the prognosis of gastric cancer liver metastasis patients with resected primary lesions.
Journal: Translational gastroenterology and hepatology
Published: September 20, 2024
Combination of LowDose Epigenetic Modifiers and TIC10 for the Activation of Antitumor Immunity and Inhibition of Tumor Growth in Gastrointestinal Cancer.
Journal: Cancer medicine
Published: September 15, 2024
STAT3-mediated up-regulation of DAB2 via SRC-YAP1 signaling axis promotes Helicobacter pylori-driven gastric tumorigenesis.
Journal: Biomarker research
Published: January 18, 2024
A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer.
Journal: Therapeutic advances in medical oncology
Published: September 07, 2023
Last Updated: 09/26/2026